Prostatis Group’s State Street SPDR Portfolio Emerging Markets ETF SPEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-33,120
Closed -$33.1K 216
2023
Q2
$33.1K Buy
+33,120
New +$1.13M 0.02% 207
2022
Q1
Sell
-5,985
Closed -$248K 98
2021
Q4
$248K Sell
5,985
-1,628
-21% -$69.6K 0.15% 88
2021
Q3
$324K Sell
7,613
-353
-4% -$15.3K 0.19% 75
2021
Q2
$362K Sell
7,966
-3,032
-28% -$136K 0.25% 72
2021
Q1
$481K Sell
10,998
-3,303
-23% -$148K 0.38% 61
2020
Q4
$603K Sell
14,301
-7,436
-34% -$295K 0.5% 47
2020
Q3
$795K Buy
21,737
+11,981
+123% +$437K 0.75% 35
2020
Q2
$326K Buy
+9,756
New +$305K 0.66% 43

Other funds holding SPEM

Prostatis Group's SPEM Position: Q3 2023 in Review

Prostatis Group sold out of State Street SPDR Portfolio Emerging Markets ETF (SPEM) in Q3 2023, closing a stake of 33,120 shares — an estimated $33.1K sold.

Prostatis Group first reported a position in SPEM in Q2 2020 and held it in 8 quarters. The position peaked at $795K in Q3 2020. 626 funds tracked by Wall St. Rank hold SPEM as of Q3 2023.

  • Prostatis Group reported no remaining State Street SPDR Portfolio Emerging Markets ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 33,120 State Street SPDR Portfolio Emerging Markets ETF shares in Q3 2023, an estimated $33.1K.
  • Prostatis Group first reported a position in State Street SPDR Portfolio Emerging Markets ETF in Q2 2020 and held it in 8 quarters.
  • Prostatis Group's State Street SPDR Portfolio Emerging Markets ETF position peaked at $795K in Q3 2020.
  • 626 funds tracked by Wall St. Rank held State Street SPDR Portfolio Emerging Markets ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.